AUROPHARMA

Aurobindo Pharma has reported a gain of 3.4% on April 11, 2025, outperforming the pharmaceuticals and drugs sector by 0.99%. The stock opened with a notable increase of 4.67% and reached an intraday high of Rs 1110, reflecting a peak gain of 4.92%. However, the stock has exhibited high volatility today, with an intraday volatility rate of 283.27%. Despite today's performance, Aurobindo Pharma is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has declined by 1.13%, while the Sensex has decreased by 0.51%. In the last month, Aurobindo Pharma's performance has remained relatively stable, with a slight decline of 0.01%, compared to a 1.18% increase in the Sensex. Year-to-date, Aurobindo Pharma has seen a decrease of 18.10%, contrasting with the Sensex's decline of 4.05%. Over a longer horizon, the stock has shown a 56.79% increase over three years and a 137.69% increase over five years, although these figures lag behind the Sensex's respective gains of 27.16% and 140.62%.